CVS vs HUM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 12, 2026

CVS

49.5
AI Score
VS
HUM Wins

HUM

66.3
AI Score

Investment Advisor Scores

CVS

50score
Recommendation
HOLD

HUM

66score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CVS HUM Winner
Forward P/E 12.987 42.3729 CVS
PEG Ratio 0.2571 2.1808 CVS
Revenue Growth 7.1% 26.2% HUM
Earnings Growth 188.8% 27.1% CVS
Tradestie Score 49.5/100 66.3/100 HUM
Profit Margin 1.2% 0.9% CVS
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY HUM

Relative Price Performance (Last 90 Days)

CVS 1M: -10.8% · 3M: -0.4% HUM 1M: -5.1% · 3M: +30.7%

Current Technical Phase

CVS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 33

RSI (14): 33.0 · Price: $94.74

HUM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.7% over 20 days), RSI 54

RSI (14): 53.9 · Price: $386.06

Fundamentals Snapshot

Metric CVS HUM
Market Cap
Forward P/E 11.0 22.5
Trailing P/E 25.2 36.4
Revenue (TTM)
Revenue Growth 0.1% 0.3%
Gross Margin 0.1% 0.1%
Operating Margin 0.0% 0.0%
EPS 3.79 10.61
Dividend Yield 0.03% 0.01%

Frequently Asked Questions

Based on our detailed analysis, HUM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.